Synergistic effects of mupirocin and an isoflavanone isolated from Erythrina variegata on growth and recovery of methicillin-resistant Staphylococcus aureus

International Journal of Antimicrobial Agents

Volumn 24, Issue 3, 2004, Pages 241-246

  Sato, Masaru ^a   Tanaka, Hitoshi ^b   Yamaguchi, Ryozo ^a   Kato, Kuniki ^b   Etoh, Hideo ^c  

^a ASAHI UNIVERSITY   (Japan)

^b MEIJO UNIVERSITY   (Japan)

^c SHIZUOKA UNIVERSITY   (Japan)

Author keywords

Anti MRSA activity; Bactericidal action; Bidwillon B; Mupirocin; Synergistic effects

Indexed keywords

BIDWILLON B; ERYTHRINA VARIEGATA EXTRACT; GLUCOSE; HERBACEOUS AGENT; ISOLEUCINE; PSEUDOMONIC ACID; THYMIDINE; UNCLASSIFIED DRUG; URIDINE; ANTIINFECTIVE AGENT; ISOFLAVANONE; ISOFLAVONE DERIVATIVE;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG EFFECT; ERYTHRINA VARIEGATA; GROWTH INHIBITION; ISOTOPE LABELING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYTOTHERAPY; PLANT; PRIORITY JOURNAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG POTENTIATION; ERYTHRINA; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS;

ERYTHRINA VARIEGATA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; DRUG SYNERGISM; ERYTHRINA; GLUCOSE; ISOFLAVONES; ISOLEUCINE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MUPIROCIN; STAPHYLOCOCCUS AUREUS; THYMIDINE; URIDINE;

EID: 4344657761     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.03.020     Document Type: Article

References (34)

1. Mulligan M.E., Murray-Leisure K.A., Ribner B.S., et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med. 94:1993;313-328
2. Brumfitt W., Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med. 320:1989;1188-1196
3. Cookson B., Peters B., Webster M., Phillips I., Rahman M., Noble W. Staff carriage of epidemic methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 27:1989;1471-1476
4. Chow J.P., Yu V.L. Staphylococcus aureus nasal carriage in hemodialysis patient: its role in infection and approaches to prophylaxis. Arch Intern Med. 149:1989;1258-1262
5. Muder R.R., Brennen C., Wagener M.M., et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med. 114:1991;107-112
6. Hill R.L.R., Duckworth G.J., Casewell M.W. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak. J Antimicrob Chemother. 22:1988;377-384
7. Cederna J.E., Terpenning M.S., Ensberg M., Bradley S.F., Kauffman C.A. Staphylococcus aureus nasal colonization in a nursing home: eradication with mupirocin. Infect Control Hosp Epidemiol. 11:1990;13-16
8. Reagan D., Doebbeling B.N., Pfaller M.A., et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med. 114:1991;101-106
9. Kavi J., Andrews J.M., Wise R. Mupirocin-resistant Staphylococcus aureus. Lancet. 2:1987;1472
10. Smith G.E., Kennedy C.T.C. Staphylococcus aureus resistant to mupirocin. J Antimicrob Chemother. 21:1988;141-142
11. Cookson B.D. Mupirocin resistance in staphylococci. J Antimicrob Chemother. 25:1990;497-503
12. Balandrin M.F., Klocke J.A., Wurtele E.S., Bollinger W.H. Natural plant chemicals: sources of industrial and medicinal materials. Science. 228:1985;1154-1160
13. Pathak D., Pathak K., Singla A.K. Flavonoids as medicinal agents - recent advances. Fitoteratia. 62:1991;371-385
14. Tanaka H., Hirata M., Etoh H., et al. Three new isoflavonoids from Erythrina variegata. Heterocycles. 55:2001;2341-2347
15. National Committee for Clinical Standards: Standard M2-A4. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Villanova: National Committee for Clinical Laboratory Standards; 1990.
16. Fan W., Busto R.D., Love M., et al. Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections. Antimicrob Agents Chemother. 29:1986;26-29
17. Krogstand DJ, Moellering RC. Antimicrobial combinations. In: Lorian V, editor. Antibiotics in Laboratory Medicine. Baltimore: Williams and Wilkins; 1986.
18. Didry N., Dubreuil L., Pinkas M. Microbiological properties of protoanemonin isolated from Ranunculus bulbosus. Phytother Res. 7:1993;21-24
19. Sato M., Tsuchiya H., Miyazaki T., et al. Antibacterial activity of hydroxychalcone against methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 6:1995;227-231
20. Telikepalli H., Gollapudi S.R., Keshavarz A., et al. Isoflavonoids and a cinnamyl phenol from root extracts of Erythrina variegata. Phytochemistry. 29:1990;2005-2007
21. 2 inhibitors from Erythrina species from Samoa. J Nat Prod. 60:1997;537-539
22. Tanaka H., Sato M., Fujiwra S., Hirata M., Etoh H., Takeuchi H. Antibacterial activity of isoflavonoids isolated from Erythrina variegata against methicillin-resistant Staphylococcus aureus. Lett Appl Microbiol. 35:2002;494-498
23. Tsuchiya H., Sato M., Miyazaki T., et al. Comparative study on antibacterial activity of phytochemical flavanones against methicillin-resistant Staphylococcus aureus. J Ethnopharmacol. 50:1996;27-34
24. Iinuma M., Tsuchiya H., Sato M., et al. Flavanones with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. J Pharm Pharmacol. 46:1994;892-895
25. Nanayakkara N.P.D., Burandt C.L. Jr., Jacob M.R. Flavonoids with activity against methicillin-resistant Staphylococcus aureus from Dalea scandens var. paucifolia. Planta Med. 68:2002;519-522
26. Sato M., Tanaka H., Yamaguchi R., Oh-Uchi T., Etoh H. Erythrina poeppigiana-derived phytochemical exhibiting antimicrobial activity against Candida albicans and methicillin-resistant Staphylococcus aureus. Lett Appl Microbiol. 37:2003;81-85
27. Casewell M.W., Hill R.L.R. Mupirocin ('pseudomonic acid') - a promising new topical antimicrobial agent. J Antimicrob Chemother. 19:1987;1-5
28. Casewell MW, Hill RLR. The laboratory assessment of the anti-staphylococcal activity of mupirocin (pseudomonic acid). In: Proceedings of the Royal Society International Congress and Symposium Series 80; 1984. p. 57-64.
29. Rahman M., Noble W.C., Cookson B. Mupirocin-resistant Staphylococcus aureus. Lancet. 2:1987;387
30. Matsuda K., Asahi Y., Sanada M., Nakagawa S., Tanaka N., Inoue M. In vitro activity of imipenem combined with β-lactam antibiotics for methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 27:1991;809-815
31. Sato M., Tsuchiya H., Takase I., Kureshiro H., Tanigaki S., Iinuma M. Antibacterial activity of flavanone isolated from Sophora exigua against methicillin-resistant Staphylococcus aureus and its combination with antibiotics. Phytother Res. 9:1995;509-512
32. Liu L.X., Durham D.G., Richards M.E. Vancomycin resistance reversal in enterococci by flavonoids. J Pharm Pharmacol. 53:2001;129-132
33. Tsuchiya H., Iinuma M. Reduction of membrane fluidity by antibacterial sophoraflavanone G isolated from Sophora exigua. Phytomedicine. 7:2000;161-165
34. Sato M., Tanaka H., Fujiwara S., et al. Antibacterial property of isoflavonoids isolated from Erythrina variegata against cariogenic oral bacteria. Phytomedicine. 10:2003;427-433